BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31475837)

  • 1. Diagnosis of pre-sarcopenia from a single selectional crosscut at C3 region, using CT scans before radiotherapy.
    Muresan BT; Sánchez Juan C; Artero A; Hernández Machancoses A; Almendros-Blanco P; Montoro A; Sánchez Jordá G; Marco-Alacid C; Ríos Ríos J; Soriano Del Castillo JM; Sánchez Guillén L; López-Torrecilla J
    Nutr Hosp; 2019 Oct; 36(5):1101-1108. PubMed ID: 31475837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of body composition in cancer patients using CT planning scan at the third lumbar vertebra.
    Muresan BT; Sánchez Juan C; Artero A; Hernández Machancoses A; Almendros-Blanco P; Montoro A; Roselló Ferrando J; Íñigo Valdenebro R; Ríos Ríos J; Soriano Del Castillo JM; Quirante Cascales JV; López-Torrecilla J
    Nutr Hosp; 2019 Dec; 36(6):1307-1314. PubMed ID: 31718205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    Yoon JK; Jang JY; An YS; Lee SJ
    PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
    Şahin MEH; Akbaş F; Yardimci AH; Şahin E
    BMC Cancer; 2023 Sep; 23(1):911. PubMed ID: 37770828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
    Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
    Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: a systematic review.
    Vangelov B; Bauer J; Kotevski D; Smee RI
    Br J Nutr; 2022 Mar; 127(5):722-735. PubMed ID: 33910664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
    PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference Data and T-Scores of Lumbar Skeletal Muscle Area and Its Skeletal Muscle Indices Measured by CT Scan in a Healthy Korean Population.
    Kim EH; Kim KW; Shin Y; Lee J; Ko Y; Kim YJ; Lee MJ; Bae SJ; Park SW; Choe J; Kim HK
    J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(2):265-271. PubMed ID: 32179888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.
    Zwart AT; Becker JN; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur Radiol; 2021 Jun; 31(6):4053-4062. PubMed ID: 33219847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
    Özkul B; Özkul Ö; Bilir C
    Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
    Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
    Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer.
    Lee JS; Kim YS; Kim EY; Jin W
    PLoS One; 2018; 13(8):e0202700. PubMed ID: 30125312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma.
    Benadon B; Servagi-Vernat S; Quero L; Cattan P; Guillerm S; Hennequin V; Aparicio T; Lourenço N; Bouché O; Hennequin C
    Dig Liver Dis; 2020 Sep; 52(9):1047-1052. PubMed ID: 32493629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management.
    Jalal M; Campbell JA; Wadsley J; Hopper AD
    J Gastrointest Cancer; 2021 Sep; 52(3):1183-1187. PubMed ID: 34292498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sarcopenia, clinical data, and 2-[
    Anconina R; Ortega C; Metser U; Liu ZA; Suzuki C; McInnis M; Darling GE; Wong R; Taylor K; Yeung J; Chen EX; Swallow CJ; Bajwa J; Jang RW; Elimova E; Veit-Haibach P
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1012-1020. PubMed ID: 34491404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prediction model for skeletal muscle evaluation and computed tomography-defined sarcopenia diagnosis in a predominantly overweight cohort of patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):321-328. PubMed ID: 35835910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle Reference Values From Thoracic and Abdominal CT for Sarcopenia Assessment: The Framingham Heart Study.
    Tonnesen PE; Mercaldo ND; Tahir I; Dietrich AW; Amayri W; Graur A; Allaire B; Bouxsein ML; Samelson EJ; Kiel DP; Fintelmann FJ
    Invest Radiol; 2024 Mar; 59(3):259-270. PubMed ID: 37725490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.